4,4',4''-((1,3,5-Triazine-2,4,6-triyl)tris(oxy))trianiline, 97%, 1g

4-FLUORO-1H-INDAZOLE-5-CARBOXYLIC ACID, 95%, 500mg

2-(5-Fluoro-2-methyl-3-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

2-(1-Benzylpiperidin-4-yl)ethanamine, 97.0%, 5g

(R)-(-)-2-Phenylpropionic Acid>98.0%(GC)(T)5g

(4-((3-Methoxypropoxy)methyl)phenyl)boronic acid, 97%, 100mg

1-(3-Bromophenyl)imidazolidin-2-one, 98%, 100mg

(R)-3-Fluoropiperidine hydrochloride, 97%, 5g

4-Fluoro-2-(trifluoromethyl)phenylisothiocyanate, 95.0%, 1g

TRANS-2-METHYLCYCLOPENTANOL, 95.0%, 5g

8-Azaspiro[bicyclo[3.2.1]octane-3,4'-imidazolidine]-2',5'-dione hydrochloride, 95%, 1g

5-Phenyl-3H-oxazol-2-one, 250mg

1,2,3,4-Tetrahydro-7-nitroquinoline, 95.0%, 1g